wpe2A.jpg (34148 bytes)

wpe51.jpg (1121 bytes) wpe50.jpg (1092 bytes) wpe52.jpg (1143 bytes) wpe53.jpg (1142 bytes)

wpe57.jpg (1158 bytes) wpe54.jpg (1085 bytes) wpe55.jpg (1102 bytes) wpe56.jpg (1157 bytes) wpe58.jpg (1157 bytes) wpe5F.jpg (1205 bytes) wpe59.jpg (1223 bytes) wpe5E.jpg (1146 bytes) wpe5A.jpg (1225 bytes) wpe5B.jpg (1221 bytes) wpe5C.jpg (1116 bytes) wpe5D.jpg (1171 bytes)

Published Adverse Reactions to Mumps Vaccination

    The Mumps Vaccine and Neurological Disorders:

  • Bottiger, M., et al. “Swedish experience og two dose vaccination programme aiming at eliminating measles, mumps and rubella.” British Medical Journal 1987; 295:264-67.
  • Thomas, E. “A case of mumps meningitis: A complication of vaccination?” Journal of the Canadian Medical Association 1988; 138:135.
  • Champagne, S., et al. “A case of mumps meningitis: a post-immunization complication?” Canadian Disease Weekly Report 1988; 13-35:155-156.
  • Ehrengut, W. “Mumps vaccine and meningitis.” Lancet 1989; 2:751.
  • Von Muhlendahl, K.E. “Mumps meningitis following measles, mumps and rubella immunisations.” Lancet (August 12, 1989), p. 394.
  • Cizman, M., et al. “Aseptic meningitis after vaccination against measles and mumps.” Pediatric Infectious Disease Journal 1989; 8:302-308.
  • McDonald, J., et al. “Clinical and epidemiological features of mumps meningo-encephalitis and possible vaccine-related disease.” Pediatric Infectious Disease Journal (November 1989), pp. 751-754.
  • Gray, J.A., et al. “Mumps meningitis following measles, mumps, and rubella immunisation.” Lancet 1989; i:98.
  • Gray, J.A., et al. “Mumps vaccine meningitis.” Lancet 1989; i:927.
  • Murray, M.W., et al. “Mumps meningitis after measles, mumps, and rubella immunisation.” Lancet 1989; ii:877.\
  • “Mumps meningitis and MMR vaccination.” [Editorial] Lancet 1989; ii:1015-1016.
  • Forsey, T., et al. “Mumps viruses and mumps, measles, and rubella vaccine.” British Medical Journal 1989; 299:1340.
  • Forsey, T., et al. “Mumps vaccines and meningitis.” Lancet 1992; 340:980.
  • Miller, E., et al. “Risk of aseptic meningitis after measles, mumps, and rubella vaccine in U.K. children.” Lancet 1993; 341:979.
  • Sawada, et al. Lancet 1993; 342:371.

    The Mumps Vaccine and Meningitis Attack Rates:

  • Sugiura, A., et al. “Aseptic meningitis as a complication of mumps vaccination.” Journal of Pediatric Infectious Diseases 1991; 10:209-213. [1 case of meningitis per 2000 doses of mumps vaccine.]
  • Fujinaga, T., et al. “A prefecture-wide survey of mumps meningitis associated with measles, mumps and rubella vaccine.” Journal of Pediatric Infectious Diseases 1991; 10:204-209. [6 cases of meningitis per 2000 doses of mumps vaccine.]
  • Colville, A., et al. “Mumps meningitis and measles, mumps, and rubella vaccine.” Lancet 1992; 340:786. [1 case of meningitis per 3800 doses of mumps vaccine.]

    The Mumps Vaccine and Diabetes:

  • Sultz, H.A., et al. “Is mumps virus an etiologic factor in juvenile diabetes mellitus?” Journal of Pediatrics 1975; 86:654-656.
  • Sinaniotis, C.A., et al. “Diabetes mellitus after mumps vaccination (letter).” Archives of Disease in Childhood 1975; 50:749-750.
  • Quast, U., et al. “Vaccine-induced mumps-like diseases.” Developments in Biological Standardization 1979; 43:269-272.
  • Otten, A., et al. “Mumps, mumps vaccination, islet cell antibodies and the first manifestation of diabetes mellitus type I.” Behring Institute Mitteilungen 1984; 75:83-88.
  • Helmke, K., et al. “Islet cell antibodies and the development of diabetes mellitus in relation to mumps infection and mumps vaccination.” Diabetologia 1986; 29:30-33.
  • Fescharek, R., et al. “Measles-mumps vaccination in the FRG: an empirical analysis after 14 years of use. II. Tolerability and analysis of spontaneously reported side effects.” Vaccine 1990; 8:446-456.
  • Pawlowski, B., et al. “Mumps vaccination and type-1 diabetes.” Deutsche Medizinische Wochenschrift 1991; 116:635.
  • Adler, J.B., et al. “Pancreatitis caused by measles, mumps, and rubella vaccine.” Pancreas 1991; 6:489-490.
  • Albonico, H., Klein, P., et al. “The immunization campaign against measles, mumps and rubella—coercion leading to a realm of uncertainty: medical objections to a continued MMR immunization campaign in Switzerland.” JAM 1992; 9(1). [180 European medical doctors jointly noted that the mumps vaccine "can trigger diabetes, which only becomes apparent months after vaccination."]

    Atypical Mumps:

  • Gunby, P. “‘Atypical’ mumps may occur after immunization.” Journal of the American Medical Association 1980; 243(23): 2374-75.
  • Family Practice News (July 15, 1980), p. 1.

    The Mumps Vaccine is Often Ineffective and Alters the Epidemiology of the Disease (It Causes Higher Rates of Mumps in High-Risk Groups):

  • Fiumara, N.J., et al. “Mumps outbreak in Westwood, Massachusetts—1981.” MMWR 1982; 33(29):421-430.
  • Kaplan, K.M., et al. “Further evidence of the changing epidemiology of a childhood vaccine-preventable disease.” Journal of the American Medical Association 1988; 260(10):1434-1438.
  • Briss, P. A., et al. “Sustained transmission of mumps in a highly vaccinated population: assessment of vaccine failure and waning vaccine-induced immunity.” Journal of Infectious Diseases 1994; 169:77-82.
  • Sawada, et al. Lancet 1993; 342:371.
  • CDC. “Mumps—United States, 1985-1988.” MMWR 1989; 38:101-05.

    Girls who contract mumps naturally during childhood are less likely to develop ovarian cancer in later life:

  • West, R. “Epidemiologic study of malignancies of the ovaries.” Cancer 1966; 19:1001-1007.
  • Wynder, E., et al. “Epidemiology of cancer of the ovary.” Cancer 1969; 23:352.
  • Newhouse, M., et al. “A case control study of carcinoma of the ovary.” Brit J Prev Soc Med 1977; 31:148-53.
  • McGowan, L., et al. “The woman at risk from developing ovarian cancer.” Gynecol Oncol 1979; 7:325-344.